HomeTBPH • NASDAQ
add
Theravance Biopharma Inc
Previous close
$9.05
Day range
$8.68 - $9.05
Year range
$7.44 - $10.44
Market cap
431.75M USD
Avg Volume
182.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 16.87M | 7.49% |
Operating expense | 16.88M | 4.54% |
Net income | -12.70M | -41.88% |
Net profit margin | -75.28 | -32.00% |
Earnings per share | -0.06 | -333.82% |
EBITDA | -8.85M | -6.22% |
Effective tax rate | -26.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.36M | -31.82% |
Total assets | 356.10M | -13.90% |
Total liabilities | 170.45M | 1.79% |
Total equity | 185.65M | — |
Shares outstanding | 49.17M | — |
Price to book | 2.39 | — |
Return on assets | -6.46% | — |
Return on capital | -9.85% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.70M | -41.88% |
Cash from operations | -5.20M | -109.01% |
Cash from investing | -17.40M | -82,752.38% |
Cash from financing | -372.00K | 98.82% |
Net change in cash | -22.97M | 32.27% |
Free cash flow | -1.06M | 6.92% |
About
Founded
2013
Website
Employees
99
